<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12866-019-1552-1</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">12866</journal-id><journal-title-group><journal-title>BMC Microbiology</journal-title><abbrev-journal-title abbrev-type="publisher">BMC Microbiol</abbrev-journal-title></journal-title-group><issn pub-type="epub">1471-2180</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12866-019-1552-1</article-id><article-id pub-id-type="manuscript">1552</article-id><article-id pub-id-type="doi">10.1186/s12866-019-1552-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="article-collection" specific-use="SubjectSection"><subject>Microbe-host interactions and microbial pathogenicity</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Change of intestinal microbiota in cerebral ischemic stroke patients</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Li</surname><given-names>Na</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Wang</surname><given-names>Xingcui</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Sun</surname><given-names>Congcong</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Wu</surname><given-names>Xinwei</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Lu</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Si</surname><given-names>Youfeng</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" id="Au7"><name><surname>Ye</surname><given-names>Xiang</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au8"><name><surname>Wang</surname><given-names>Tan</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au9"><name><surname>Yu</surname><given-names>Xiaolin</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au10"><name><surname>Zhao</surname><given-names>Xinjing</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au11"><name><surname>Wei</surname><given-names>Na</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au12"><name><surname>Wang</surname><given-names>Xingbang</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="corresp" rid="IDs1286601915521_cor12">n</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.479672.9</institution-id><institution content-type="org-division">Department of Dermatology</institution><institution content-type="org-name">Affiliated Hospital of Shandong University of Traditional Chinese Medicine</institution></institution-wrap><addr-line content-type="postcode">250011</addr-line><addr-line content-type="city">Jinan</addr-line><addr-line content-type="state">Shandong</addr-line><country country="CN">China</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1761 1174</institution-id><institution-id institution-id-type="GRID">grid.27255.37</institution-id><institution content-type="org-division">Department of Nephrology</institution><institution content-type="org-name">Qilu Children’s Hospital of Shandong University</institution></institution-wrap><addr-line content-type="postcode">250022</addr-line><addr-line content-type="city">Jinan</addr-line><country country="CN">China</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.452402.5</institution-id><institution content-type="org-division">Department of Neurology</institution><institution content-type="org-name">Qilu Hospital of Shandong University</institution></institution-wrap><addr-line content-type="postcode">250012</addr-line><addr-line content-type="city">Jinan</addr-line><country country="CN">China</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.452402.5</institution-id><institution content-type="org-division">Department of Geriatric Medicine</institution><institution content-type="org-name">Qilu Hospital of Shandong University; Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University</institution></institution-wrap><addr-line content-type="postcode">250012</addr-line><addr-line content-type="city">Jinan</addr-line><country country="CN">China</country></aff><aff id="Aff5"><label>5</label><institution-wrap><institution content-type="org-division">Department of Neurology</institution><institution content-type="org-name">Feicheng Mining Center Hospital of Shandong Province</institution></institution-wrap><addr-line content-type="postcode">271608</addr-line><addr-line content-type="city">Feicheng, Tai an</addr-line><country country="CN">China</country></aff></contrib-group><author-notes><corresp id="IDs1286601915521_cor12"><label>n</label><email>20893792@qq.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>8</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>19</volume><issue seq="191">1</issue><elocation-id>191</elocation-id><history><date date-type="registration"><day>24</day><month>7</month><year>2019</year></date><date date-type="received"><day>5</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>24</day><month>7</month><year>2019</year></date><date date-type="online"><day>19</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">Gut microbiota has been suggested to play a role in stroke patients. Nevertheless, little is known about gut microbiota and the clinical indexes in stroke patients.</p></sec><sec id="ASec2"><title>Methods</title><p id="Par2">Total of 30 cerebral ischemic stroke (CI) patients and 30 healthy control were enrolled in this study and the fecal gut microbiota was profiled via Illumina sequencing of the 16S rRNA V1-V2. The National Institutes of Health Stroke Scale (NIHSS) were used to quantify stroke severity and modified Rankin scale (mRS) to assess outcome for CI patients. The correlations between the clinical indexes and microbiota were evaluated.</p></sec><sec id="ASec3"><title>Results</title><p id="Par3">Though the microbial α-diversity and structure is similar between CI patients and healthy controls, the gut microbiota of CI patients had more short chain fatty acids producer including <italic>Odoribacter</italic>, <italic>Akkermansia, Ruminococcaceae_</italic>UCG_005 and <italic>Victivallis</italic>. We also found that the special microbes were correlation with serum index, such as norank_O<italic>_ _Mollicutes_RF9</italic>, <italic>Enterobacter</italic>, <italic>Ruminococcaceae</italic>_UCG-002 were negative correlation with LDL (r = − 0.401, <italic>P</italic> &lt; 0.01), HDL (r = − 0.425, <italic>P</italic> &lt; 0.01) and blood glucose (r = − 0.439, <italic>P</italic> &lt; 0.001), while the HDL was significantly positive correlation with the genus <italic>Ruminococcus</italic>_1 (r = 0.443, <italic>P</italic> &lt; 0.001). The <italic>Christensenellaceae</italic>_R-7_group and norank_f_<italic>Ruminococcaceae</italic> was significantly positive correlation with NIHSS1M (r = 0.514, <italic>P</italic> &lt; 0.05; r = 0.449, <italic>P</italic> &lt; 0.05) and mRS (r = 0.471, <italic>P</italic> &lt; 0.05, r = 0.503, <italic>P</italic> &lt; 0.01), respectively. On the other hand, the genus <italic>Enterobacter</italic> was significantly negative correlation with NIHSS1M (r = 0.449, <italic>P</italic> &lt; 0.05) and mRS (r = 0.503, <italic>P</italic> &lt; 0.01).</p></sec><sec id="ASec4"><title>Conclusions</title><p id="Par4">This study suggests that CI patients showed significant dysbiosis of the gut microbiota with enriched short chain fatty acids producer, including <italic>Odoribacter</italic>, <italic>Akkermansia</italic>. This dysbiosis was correlation with the outcomes and deserves further study.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Cerebral ischemic stroke</kwd><kwd>Microbiota</kwd><kwd>Dysbiosis</kwd><kwd>Outcomes</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Shandong Provincial Natural Science Foundation, China</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">ZR2016HB37</award-id><principal-award-recipient><name><surname>Lu</surname><given-names>Mei</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Shandong Medical Science and Technology Development Plan Project</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">2017WS433</award-id><award-id award-type="FundRef grant">2017WSA01044</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Na</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Wang</surname><given-names>Xingcui</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Science and technology projects of Jinan health and family planning commission </institution></institution-wrap></funding-source><award-id award-type="FundRef grant">2016-1-50</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Xingcui</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>7</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>24</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12866_2019_Article_1552.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Life Sciences</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Biological Microscopy</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Mycology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Parasitology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Virology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Life Sciences, general</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Biomedical and Life Sciences</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="AuthorContribution"><p>Na Li, Xingcui Wang, Congcong Sun and Xinwei Wu contributed equally to this work.</p></notes><notes notes-type="ESMHint"><title>Electronic supplementary material</title><p>The online version of this article (<ext-link xlink:href="https://doi.org/10.1186/s12866-019-1552-1" ext-link-type="doi">https://doi.org/10.1186/s12866-019-1552-1</ext-link>) contains supplementary material, which is available to authorized users.</p></notes></front><body><sec id="Sec1"><title>Background</title><p id="Par13">Cerebrovascular accidents (stroke) is brain injury caused by disruption the supply of blood to a brain region, which could result in permanent neurological deficits or death [<xref ref-type="bibr" rid="CR1">1</xref>]. Now, stroke is global health problem and now became to the second leading cause of death as well as the third leading cause of disability [<xref ref-type="bibr" rid="CR2">2</xref>]. Basing on the underlying pathology, the stroke was classified to ischemic and hemorrhagic stroke [<xref ref-type="bibr" rid="CR2">2</xref>]. The cerebral Ischemic stroke (CI) is responsible for 85% of all strokes, and the hemorrhagic stroke accounts for about the rest 15% [<xref ref-type="bibr" rid="CR2">2</xref>]. The most ischemic stroke is caused by the middle cerebral artery occlusion, resulting in the brain tissue damage in the affected territory, which is followed by inflammatory and immune response [<xref ref-type="bibr" rid="CR1">1</xref>]. Despite the stroke debilitated the neurological deficits, infection is the superior cause of death after stroke [<xref ref-type="bibr" rid="CR3">3</xref>]. It was found that 90 % of stroke cases may be correlated with behavioral factors including poor diet, smoking, and low physical activity as well as metabolic factors including obesity, hypertension, diabetes mellitus. Previous study also found that gut microbiota might be as a risk factor for stroke [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par14">The gastrointestinal tract is thought to be a major immune organ which was equipped with the largest pool of immune cells, accounting for more than 70% of the entire immune system. More and more evidences propose that the gut inflammatory along with immune response plays an essential role in the pathophysiology of stroke and this may become an important therapeutic target for treatment of stroke [<xref ref-type="bibr" rid="CR5">5</xref>]. It was found that gut microbiota plays a vital role in regulation of the immune system. The gut microbiota was also revealed to be an important influence factor for stroke in a mouse model [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR9">9</xref>]. In addition, stroke usually cause gut dysmotility, gut microbiota dysbiosis, gut hemorrhage, as well as gut-origin sepsis, resulting in poor prognosis. However, there are little about the characteristics of gut microbiota from stroke patient [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par15">This study aims to determine the characteristic of gut microbiota of stroke patient. We also evaluated the relations between gut microbiota and serum indexes or outcome by Spearman’s rank correlation.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Subjects</title><p id="Par16">Total of 60 subjects, including 30 CI (21 males, 9 females) and 30 healthy control (18 males, 12 females) were recruited in this study (Table <xref rid="Tab1" ref-type="table">1</xref>). It was found that there were no significant differences in gender (male: 70. % vs. 60.0%, <italic>P</italic> = 0.42) and age (60.47 ± 10.57 vs. 64.17 ± 12.67, <italic>P</italic> = 0.31) between the CI group and healthy control group. The LDL, GLU, UA, TG, HCY of CI patients were similar with the healthy control. The HDL of CI patients was lower than that of healthy control group (1.10 ± 0.19 vs. 1.29 ± 0.24, <italic>P</italic> &lt; 0.01) (Table <xref rid="Tab1" ref-type="table">1</xref>). The NIHSS at 7d (NIHSS 1 W) and 1 month (NIHSS 1 M), modulate RANK score (mRS) and serum index of each subjects were shown in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Table S1 and Additional file <xref ref-type="supplementary-material" rid="MOESM2">2</xref>: Table S2.
<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Characteristics of the study participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><p>CI (<italic>n</italic> = 30)</p></th><th><p>HC (n = 30)</p></th><th><p><italic>P</italic></p></th></tr></thead><tbody><tr><td><p>Sex (male, %)</p></td><td><p>21 (70%)</p></td><td><p>18 (60%)</p></td><td><p>0.42</p></td></tr><tr><td><p>Age</p></td><td><p>60.47 ± 10.57</p></td><td><p>64.17 ± 12.67</p></td><td><p>0.31</p></td></tr><tr><td><p>LDL</p></td><td><p>2.20 ± 0.68</p></td><td><p>2.30 ± 0.50</p></td><td><p>0.51</p></td></tr><tr><td><p>HDL</p></td><td><p>1.10 ± 0.19</p></td><td><p>1.29 ± 0.24</p></td><td><p>&lt; 0.01</p></td></tr><tr><td><p>UA</p></td><td><p>303.8 ± 64.5</p></td><td><p>282.3 ± 62.7</p></td><td><p>0.20</p></td></tr><tr><td><p>GLU</p></td><td><p>4.92 ± 0.67</p></td><td><p>5.20 ± 0.76</p></td><td><p>0.14</p></td></tr><tr><td><p>HCY</p></td><td><p>12.94 ± 3.93</p></td><td><p>12.36 ± 3.33</p></td><td><p>0.54</p></td></tr><tr><td><p>TG</p></td><td><p>1.24 ± 0.47</p></td><td><p>1.33 ± 0.31</p></td><td><p>0.39</p></td></tr></tbody></table><table-wrap-foot><p><italic>HDL</italic> high-density lipoprotein, <italic>LDL</italic> low-density lipoprotein, <italic>GLU</italic> glucose of blood, <italic>UA</italic> uric acid, <italic>TG</italic> triglycerides, <italic>HCY</italic> homocysteine</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>The microbial α-diversity and structure is similar between CI and HC group</title><p id="Par17">We obtained a total of 2,191,980 high-quality sequences by quality-filtering with a coverage above 99.0%. After removing rare OTUs., 19,869 sequences per sample were obtained which were clustered to 955 OTUs. The results of bacterial community richness and diversity were shown in Table <xref rid="Tab2" ref-type="table">2</xref>. It was found that there was no difference in shannon, simpson, ace or chao index between two group.
<table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>The index of α-diversity</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><p>CI (<italic>n</italic> = 30)</p></th><th><p>HC (<italic>n</italic> = 30)</p></th><th><p><italic>P</italic></p></th></tr></thead><tbody><tr><td><p>Shannon</p></td><td><p>3.69 ± 0.52</p></td><td><p>3.59 ± 0.59</p></td><td><p>0.3515</p></td></tr><tr><td><p>Simpson</p></td><td><p>0.09 ± 0.06</p></td><td><p>0.10 ± 0.07</p></td><td><p>0.4786</p></td></tr><tr><td><p>Ace</p></td><td><p>555.68 ± 51.24</p></td><td><p>552.19 ± 43.47</p></td><td><p>0.4679</p></td></tr><tr><td><p>Chao</p></td><td><p>565.64 ± 55.61</p></td><td><p>558.79 ± 48.05</p></td><td><p>0.7775</p></td></tr></tbody></table></table-wrap></p><p id="Par18">The similarity of the bacterial community structures between CI group and healthy control group was evaluated by PCoA (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). There was no obvious difference of the microbiota structure between the 2 groups. Then, ANOSIM were performed and also found a high similarity in the bacterial community between CI patients and the healthy control based on two algorithms (unweighted unifrac, r = 0.0254, <italic>P</italic> = 0.132; weighted unifrac r = − 0.012, <italic>P</italic> = 0.649, respectively).
<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>PCoA analysis of the microbiota among CI and healthy control groups. <bold>a</bold> Weighted unifrac PCoA; <bold>b</bold> Unweighted unifrac PCoA</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12866_2019_1552_Fig1_HTML.png" id="MO1"/></p></fig></p></sec><sec id="Sec5"><title>Differentially abundant taxon in microbiota of CI patients and healthy control</title><p id="Par19">Most of the gut bacteria detected in this study falls into 3 phyla: Bacteroidetes, Firmicutes, and Proteobacteria (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a). The main genus of gut micriobiota (the percentages were above 1%) includes 24 genera and they compose up to 80% of the total microbiota, such as <italic>Bacteroides</italic>, <italic>Prevotella</italic>, <italic>Faecalibacterium</italic>, <italic>Escherichia/Shigella</italic>, <italic>Phascolarctobacterium</italic>, and <italic>Roseburia</italic> (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). The taxa that most likely reveal the differences between CI and healthy control group were identified by LEfSe (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). At the genus level, <italic>Anaerostipes</italic> and <italic>Ruminiclostridium_</italic>5 were significantly enriched in the healthy group, while <italic>Odoribacter</italic>, <italic>Akkermansia</italic>, <italic>Ruminococcaceae_</italic>UCG_005, <italic>norank_p_Flavobacteriaceae</italic>, <italic>norank_p_Parcubacteria</italic>, and <italic>Victivallis</italic> exhibited relatively higher abundance in the CI group (Fig. <xref rid="Fig3" ref-type="fig">3</xref>a). We also observed that the genus <italic>Enterobacter</italic>, <italic>Pyramidobacter</italic>, and <italic>Lachnospiraceae</italic>_UCG_001 increased in mild CI patients (NIHSS score ≤ 4) (Fig. <xref rid="Fig3" ref-type="fig">3</xref>b). While, genus Ruminococcaceae_UCG-002, Christensenellaceae_R-7_group, Ruminococcaceae_UCG-005 and norank_f_Ruminococcaceae increased in severe stroke patients (NIHSS score &gt; 4) (Fig. <xref rid="Fig3" ref-type="fig">3</xref>b).
<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>The relative taxa abundance between CI and healthy control groups. <bold>a</bold> Phylum; <bold>b</bold> Genus</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12866_2019_1552_Fig2_HTML.png" id="MO2"/></p></fig><fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p><bold>a</bold> The most differentially abundant taxa between CI and <bold>b</bold> healthy control group based on LEfSe analysis</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12866_2019_1552_Fig3_HTML.png" id="MO3"/></p></fig></p></sec><sec id="Sec6"><title>The gut microbiota was related to the clinical indices</title><p id="Par20">The serum indices of each subjects were shown in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Table S1. We try to find relationship between the gut microbiota and the serum indices including TG, LDL, HDL, UA, Glu, and Hcy by Spearman’s rank correlation coefficient. We found strong correlations (r &gt; 0.22 or &lt; − 0.22, <italic>P</italic> &lt; 0.05) between them as shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>. A significant positive correlation was exhibited between LDL and genus <italic>Bacteroides</italic> (r = 0.42, <italic>P</italic> &lt; 0.01) as well as [Eubocterium]_rectole_group (r = 0.336, <italic>P</italic> &lt; 0.01). While, it was found that norank_O<italic>_ _Mollicutes</italic>_RF9 <italic>was negative</italic> correlation with LDL (r = − 0.401, <italic>P</italic> &lt; 0.01). The HDL was significantly positive correlation with the genus <italic>Ruminococcus</italic>_1 (r = 0.443, <italic>P</italic> &lt; 0.001), Ruminococcus_2 (r = 0.381, <italic>P</italic> &lt; 0.01) and <italic>Lachnospiraceae</italic>_NK4A136_group (r = 0.338, <italic>P</italic> &lt; 0.01) and negative correlation with the genus <italic>Enterobacter</italic> (r = − 0.425, <italic>P</italic> &lt; 0.01). The UA was found positive correlation with <italic>Dialister</italic> (r = 0.279, <italic>P</italic> &lt; 0.05) and the GLU was found significantly negative correlation with <italic>Ruminococcaceae</italic>_UCG-002 (r = − 0.439, <italic>P</italic> &lt; 0.001), <italic>Alistipes</italic> (r = − 0.313, <italic>P</italic> &lt; 0.05), and <italic>Ruminococcus</italic>_1 (r = − 0.287, <italic>P</italic> &lt; 0.05). And the Hcy was found positive correlation with <italic>Megamonas</italic> (r = 0.291, <italic>P</italic> &lt; 0.05) and <italic>Fusobacterium</italic> (r = 0.297, <italic>P</italic> &lt; 0.05).
<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>Heatmap of spearman correlation analysis between the gut microbiota and the serum indices. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.01. HDL, high-density lipoprotein; LDL, low-density lipoprotein; GLU, glucose of blood; UA, uric acid; TG, triglycerides; HCY, homocysteine</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12866_2019_1552_Fig4_HTML.png" id="MO4"/></p></fig></p></sec><sec id="Sec7"><title>The gut microbiota was correlated with the severity and outcome of CI</title><p id="Par21">The severity and outcome of CI patients could be evaluated by NIHSS and mRS (Additional file <xref ref-type="supplementary-material" rid="MOESM2">2</xref>: Table S2). Then, we do the Spearman’s rank correlation coefficient analysis and attempt to explore the relationship between the gut microbiota and severity or outcome including NIHSS 1 W NIHSS 1 M and mRS (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). As a result, the genus <italic>Christensenellaceae</italic>_R-7_group was significantly positive correlation with NIHSS1W (r = 0.488, <italic>P</italic> &lt; 0.01), NIHSS1M (r = 0.514, <italic>P</italic> &lt; 0.05) and mRS (r = 0.471, <italic>P</italic> &lt; 0.05). While, the genus norank_f_<italic>Ruminococcaceae</italic> was also significantly positive correlation with NIHSS1M (<italic>r</italic> = 0.449, <italic>P</italic> &lt; 0.05) and mRS (<italic>r</italic> = 0.503, <italic>P</italic> &lt; 0.01). In contrast, the genus <italic>Enterobacter</italic> was significantly positive correlation with NIHSS1M (<italic>r</italic> = 0.449, <italic>P</italic> &lt; 0.05) and mRS (<italic>r</italic> = 0.503, <italic>P</italic> &lt; 0.01).
<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p>Heatmap of spearman correlation analysis between the gut microbiota and the outcome of CI patients. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.01</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12866_2019_1552_Fig5_HTML.png" id="MO5"/></p></fig></p></sec></sec><sec id="Sec8" sec-type="discussion"><title>Discussion</title><p id="Par22">In this study, the results demonstrate that certain changes in fecal microbiota was happened in ischemic stroke patients, such as the increasement short-chain fatty acids (SCFAs)-producing taxonomies <italic>Odoribacter</italic> and <italic>Akkermansia</italic>. Furthermore, the levels the genus <italic>Christensenellaceae</italic>_R-7_group, norank_f_<italic>Ruminococcaceae</italic>, and <italic>Enterobacter</italic> were correlated with the severity, while the level of genus <italic>Christensenellaceae</italic>_R-7_group was positively correlated with the outcome of CI patients. In addition, we also found that the microbiota was correlated with the human hematological index.</p><p id="Par23">Previous studies have proved that gut microbiota play a vital role in stroke. It was reported that depletion of gut bacteria via antibiotic administration decreased the survival rate of mice following the induction of ischemia [<xref ref-type="bibr" rid="CR11">11</xref>]. In mice, Houlden et al., found that the composition of caecal microbiota was altered by experimental stroke, such as specific changes of <italic>Peptococcaceae</italic> and <italic>Prevotellaceace</italic> [<xref ref-type="bibr" rid="CR6">6</xref>]. Benakis et al. found that the microbiota dysbiosis would affect the ischemic stroke outcome via suppressing the traffick of effector T cells from the gut to the leptomeninges in middle cerebral artery occlusion model [<xref ref-type="bibr" rid="CR9">9</xref>]. Though only a few studies have investigated the role of microbiota in stroke patient, dysregulation of the microbiota in patients following stroke have been identified [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. Yin et al., found that ischemic stroke was associated with different microbiota structure and more opportunistic pathogens, such as <italic>Megasphaera</italic>, <italic>Enterobacter</italic>, <italic>Oscillibacter</italic>, along with fewer commensal or beneficial genera such as <italic>Prevotella</italic>, <italic>Bacteroides</italic>, and <italic>Faecalibacterium</italic> [<xref ref-type="bibr" rid="CR13">13</xref>]. After that, Yamashiro et al., found that ischemic stroke was independently associated with increasement of Atopobium cluster and <italic>Lactobacillus ruminis</italic>, and decreased numbers of <italic>L. sakei</italic> subgroup based on qRT-PCR [<xref ref-type="bibr" rid="CR12">12</xref>]. In another study, gut microbiota dysbiosis was identified with increased abundance of <italic>Escherichia</italic>, <italic>Bacteroides</italic>, <italic>Megamonas</italic>, <italic>Parabacteroides</italic>, and <italic>Ruminococcus</italic> in the CI and IS patients compared with the healthy group. In the higher risk of stroke people, there was no significant change in alpha diversity index of the microbiota. However, enrichment of opportunistic pathogens together with low abundance of butyrate-producing bacteria were found in subjects with high risk of stroke [<xref ref-type="bibr" rid="CR4">4</xref>]. In this study, we also found that the microbial α-diversity and structure was similar between CI patients and healthy control. However, the <italic>Anaerostipes</italic> and <italic>Ruminiclostridium_</italic>5 were significantly enriched in the healthy group, while <italic>Odoribacter</italic>, <italic>Akkermansia</italic>, <italic>Ruminococcaceae_</italic>UCG_005, <italic>norank_p_Flavobacteriaceae</italic>, and <italic>Victivallis</italic> represented a relatively higher abundance in CI group (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a). Of them, <italic>Odoribacter</italic>, <italic>Akkermansia, Ruminococcaceae_</italic>UCG_005 and <italic>Victivallis</italic> are known producer of SCFAs, including acetate, propionate, and butyrate [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Meanwhile, significant differences within the CI group was also observed that the <italic>Enterobacter</italic>, <italic>Pyramidobacter</italic>, and <italic>Lachnospiraceae</italic>_UCG_001 increased in mild CI patients (NIHSS score ≤ 4). While, genus <italic>Ruminococcaceae</italic>_UCG-002, <italic>Christensenellaceae</italic>_R-7_group, <italic>Ruminococcaceae</italic>_UCG-005 and norank_f_<italic>Ruminococcaceae</italic> increased in severe stroke patients (NIHSS score &gt; 4) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). These results suggest that the intestinal flora may have been involved in the human stroke and correlated to the severity of CI.</p><p id="Par24">SCFAs are a major class of bacterial metabolites obtained from fermentation of otherwise indigestible polysaccharides (fibers) in the colon by bacteria [<xref ref-type="bibr" rid="CR18">18</xref>]. Preview studies indicated that SCFAs have important role in maintaining the intestinal integrity and anti-inflammatory. As a result, beneficial effects of SCFAs have been found in several disease models, such as colitis, metabolic syndrome and so on [<xref ref-type="bibr" rid="CR19">19</xref>]. In this study, we found that short-chain fatty acids (SCFAs)-producing taxonomies <italic>Odoribacter</italic> and <italic>Akkermansia</italic> increased in CI patient. <italic>Akkermansia muciniphila</italic> is the single species of genus <italic>Akkermansia</italic> in the human which accounts 1–3% of the total bacterial cells in feces [<xref ref-type="bibr" rid="CR20">20</xref>]. It was found that <italic>A. muciniphila</italic> was inversely associated with diabetes, obesity, cardiometabolic diseases and low-grade inflammation [<xref ref-type="bibr" rid="CR16">16</xref>]. Previous study demonstrated that the shift in mucosal microbial composition induced by the stroke were an increasement of <italic>A. muciniphila</italic> along with an excessive abundance of Clostridial species in mice [<xref ref-type="bibr" rid="CR8">8</xref>]. However, it was reported that <italic>Akkermansia</italic> decreased in CI patient [<xref ref-type="bibr" rid="CR14">14</xref>]. The <italic>Akkermansia</italic> was of 20% abundance of the total microbe in one normal control and this might cause statistical bias. In this study, we found that <italic>Akkermansia</italic> significantly increased in CI patient (<italic>P</italic> &lt; 0.05) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c). It was reported that <italic>A. muciniphila</italic> could use mucin to produce high levels acetate which may be consumed by butyrate-producing Ruminococcaceae to promote butyrate production [<xref ref-type="bibr" rid="CR4">4</xref>]. In this study, genus <italic>Odoribacter</italic>, a butyrate producer which belongs to phylum Bacteroidetes [<xref ref-type="bibr" rid="CR21">21</xref>], also increase in CI patient. This indicated that the simultaneous increase of these two bacteria might promote the production of butyrate. Butyrate is a preferential energy source for epithelial cells and it preserves the epithelial heath [<xref ref-type="bibr" rid="CR22">22</xref>]. Butyrate also could impact the expression level of genes which are aroused by <italic>A. muciniphila</italic> in epithelial cells [<xref ref-type="bibr" rid="CR23">23</xref>]. Therefore, Stanley et al. thought that the <italic>Akkermansia</italic> may play a crucial role in healing of wound damage via promotion the butyrate levels, resulting in consolidate epithelial integrity in the post-stroke mice [<xref ref-type="bibr" rid="CR8">8</xref>]. In addition, <italic>A. muciniphila</italic> could induce mucus production and expression of Reg3γ in colon, resulting microbiota remodeling [<xref ref-type="bibr" rid="CR24">24</xref>]. Thus, further work needs to be done to find out the possible role of <italic>Akkermansia</italic> and <italic>Odoribacter</italic> in post-stroke.</p><p id="Par25">Regarding the sequelae of a stroke, predicting the severity and outcome is important to CI patients and their families in guiding the treatment [<xref ref-type="bibr" rid="CR25">25</xref>]. Many biomarkers offer the potential to predict the outcome of stroke, including TG/HDL-C [<xref ref-type="bibr" rid="CR26">26</xref>], IL-6, NT-proBNP [<xref ref-type="bibr" rid="CR27">27</xref>], and serum YKL-40 [<xref ref-type="bibr" rid="CR28">28</xref>]. In this study, the genus <italic>Christensenellaceae</italic>_R-7_group and norank_f_<italic>Ruminococcaceae</italic> was significantly positive correlation with NIHSS1M (r = 0.514, <italic>P</italic> &lt; 0.05; r = 0.449, <italic>P</italic> &lt; 0.05) and mRS (r = 0.471, <italic>P</italic> &lt; 0.05, r = 0.503, <italic>P</italic> &lt; 0.01), respectively. On the other hand, the genus <italic>Enterobacter</italic> was significantly negative correlation with NIHSS1M (r = 0.449, <italic>P</italic> &lt; 0.05) and mRS (r = 0.503, <italic>P</italic> &lt; 0.01). Yin et al. found that opportunistic pathogens including <italic>Enterobacter</italic> enriched in stroke patients [<xref ref-type="bibr" rid="CR13">13</xref>]. However, the relationship between genus <italic>Enterobacter</italic> and the severity or outcome is unknown. We also found that the genus <italic>Enterobacter</italic> was negative correlation with the HDL-C (r = − 0.425, <italic>P</italic> &lt; 0.01), which was considered as a potential protective factor against CVD [<xref ref-type="bibr" rid="CR29">29</xref>]. Thus, these results suggested that the HDL-C was positive correlation with the NIHSS at 1 month (r = 0.449, <italic>P</italic> &lt; 0.05) and mRS and this is inconsistent with previous studies [<xref ref-type="bibr" rid="CR30">30</xref>]. On the other hand, we also found that the genus <italic>Enterobacter</italic> increased in mild CI patients (NIHSS score ≤ 4). These patients usually have a better outcome than severe CI patients. These might be the reason that the genus <italic>Enterobacter</italic> was negative correlation with NIHSS 1 M and mRS. Until now, we knew little about the genus of Christensenellaceae_R-7_group and norank_f_Ruminococcaceae. Further study to identify the potent microbial biomarkers for predicting the outcome of stroke patients need to be done.</p></sec><sec id="Sec9" sec-type="conclusions"><title>Conclusion</title><p id="Par26">This study suggests that dysbiosis of the gut microbiota in CI patients with enriched SCFAs producer, including <italic>Odoribacter</italic>, <italic>Akkermansia</italic>. This dysbiosis was correlation with the outcomes and might be used as biomarkers for the long-term outcome which clearly deserves further study.</p></sec><sec id="Sec10" sec-type="methods"><title>Methods</title><sec id="Sec11"><title>Subjects</title><p id="Par27">Total of 30 CI patients were selected. They were recruited from Qilu Hospital (Jinan, China) between May 2017 and January 2018, and had been diagnosed by skull computed tomography examination. The subjects enrolled in this study received and written the informed consent. The National Institutes of Health Stroke Scale (NIHSS) &gt; 4 was defined as severe stroke. In addition, 30 healthy volunteers who were examined to ensure that they had no metabolic, cardiovascular or cerebrovascular diseases or cancer were selected as the normal group. All these individuals did not receive antibiotics or probiotic before 4 weeks prior to the specimen collection. This study was approved by the Ethical Committee of the Qilu Hospital of Shandong University (Jinan, China).</p></sec><sec id="Sec12"><title>Sample collection and 16S rRNA sequencing</title><p id="Par28">The first available fecal samples of CI patients after admission (within 48 h) were collected. The samples and its genomic DNA were immediately frozen in liquid nitrogen and then stored at − 80 °C. Genomic DNA of microbes in fecal samples was extracted by CTAB assay. About 1 mg of each sample was used for DNA quantification by a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA).</p><p id="Par29">For analyzing the microbial populations, amplification of the V1-V2 region of the 16S rRNA gene was performed via barcode-indexed primers 27F: 5′ AGAGTTTGATCMTGGCTC G, 338R-I 5′ GCWGCCTCCCGTAGGAGT, and 338R-II 5′ GCWGCCACCCGTAGGTGT). Then, we used the QIAquick PCR Purification Kit (Qiagen, Barcelona, Spain) to purified PCR amplicons and the products were quantified by a spectrophotometer as before. After that, it was pooled in equal concentration and 2 nM of pooled amplicons were then sequenced by Illumina MiSeq sequencer following the standard protocols.</p></sec><sec id="Sec13"><title>Analysis of the microbiota</title><p id="Par30">Trimmomatic was used to demultiplexed and quality-filtered the Raw data. The obtained data was merged by FLASH compliance with rules: (i) The reads attaining an average quality score less than 20 in a sliding window of 50 bp were deleted. (ii) Primers were only allowing 2 nucleotides mismatching, meanwhile reads containing ambiguous bases were deleted. (iii) Sequences containing overlap over 10 bp were merged through the overlap sequence.</p><p id="Par31">Majorbio I-Sanger Cloud Platform was used to analyze the microbiota (<ext-link xlink:href="https://www.i-sanger.com" ext-link-type="url">https://www.i-sanger.com</ext-link>). We used the UPARSE to clustered the operational taxonomic units (OTUs) with a cutoff of 97% similarity (version 7.1) as well as UCHIME were used to identified and removed chimeric sequences. RDP Classifier was used to analyzed the taxonomy of each sequence through algorithm against the Silva (SSU128) 16S rRNA database by a confidence threshold of 70% (<ext-link xlink:href="http://rdp.cme.msu.edu/" ext-link-type="url">http://rdp.cme.msu.edu/</ext-link>).</p><p id="Par32">We normalized the OTUs abundance of each sample based on the least sequences number of all samples and removed the rare OTUs. Then, it was used to analyze the alpha diversity and beta diversity by QIIME tool. Meanwhile, linear discriminant analysis (LDA) effect size (LEfSe) analyses were carried out through the LEfSe tool with an LDA of 2.0. The analysis of similarity (ANOSIM) test were used to evaluate the differences of microbial structure between CI patients and healthy control.</p></sec><sec id="Sec14"><title>Biochemical assays</title><p id="Par33">Blood samples were gathered from patients with stroke at admission and from healthy subjects at physical examination center. Serum levels of low-density lipoprotein (LDL), glucose of blood (GLU), high-density lipoprotein (HDL), uric acid (UA), triglycerides (TG), and homocysteine (HCY) were measured using standard techniques.</p></sec><sec id="Sec15"><title>Statistic methods</title><p id="Par34">All data are demonstrated as mean ± SD. The normality of the distribution had been demonstrated with Kolmogorov-Smirnoff statistic of the data. The Chi-square-tests was used to assess gender. The T-tests was used for analysis of continuous variables. Spearman’s rank correlation was used to analysis of statistical dependence of continuous variables. <italic>P</italic>-values &lt; 0.05 were considered as statistically significant. Analyses were carried out through the SPSS statistical package, version 24.0.</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>All authors participated in the conception and design of the study; conceived and drafted the manuscript: NL, XCW; performed the experiments: NL, XCW, CCS, XWW, XJZ, NW and XBW; collected the basic patient information, clinical indicators, and imaging data: ML, XY, TW, and XLY; analyzed the data: CCS and XBW; revised the paper: CCS, XWW and XBW. All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>This research was supported by Shandong Provincial Natural Science Foundation, China (Grant NO. ZR2016HB37), the Shandong Medical Science and Technology Development Plan Project (NO. 2017WS433 and 2017WSA01044), Science and technology projects of Jinan health and family planning commission (NO. 2016-1-50).</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this published article.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par35">The protocol of this study was approved by the local Ethical Committee of the Qilu Hospital of Shandong University (KYLL-2017(KS)-088). All volunteers received information concerning their participation in the study and gave written informed consent.</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par36">Not applicable.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par37">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossmann</surname><given-names>KA</given-names></name></person-group><article-title xml:lang="en">Pathophysiology and therapy of experimental stroke</article-title><source>Cell Mol Neurobiol</source><year>2006</year><volume>26</volume><issue>7–8</issue><fpage>1057</fpage><lpage>1083</lpage><pub-id pub-id-type="pmid">16710759</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parr</surname><given-names>Emma</given-names></name><name><surname>Ferdinand</surname><given-names>Phillip</given-names></name><name><surname>Roffe</surname><given-names>Christine</given-names></name></person-group><article-title xml:lang="en">Management of Acute Stroke in the Older Person</article-title><source>Geriatrics</source><year>2017</year><volume>2</volume><issue>3</issue><fpage>27</fpage><pub-id pub-id-type="doi">10.3390/geriatrics2030027</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamorro</surname><given-names>Ángel</given-names></name><name><surname>Urra</surname><given-names>Xabier</given-names></name><name><surname>Planas</surname><given-names>Anna M.</given-names></name></person-group><article-title xml:lang="en">Infection After Acute Ischemic Stroke</article-title><source>Stroke</source><year>2007</year><volume>38</volume><issue>3</issue><fpage>1097</fpage><lpage>1103</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000258346.68966.9d</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Zeng X, et al. Higher risk of stroke is correlated with increased opportunistic pathogen load and reduced levels of butyrate-producing Bacteria in the gut. Front Cell Infect Microbiol. 2019;9:4.</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iadecola</surname><given-names>Costantino</given-names></name><name><surname>Anrather</surname><given-names>Josef</given-names></name></person-group><article-title xml:lang="en">The immunology of stroke: from mechanisms to translation</article-title><source>Nature Medicine</source><year>2011</year><volume>17</volume><issue>7</issue><fpage>796</fpage><lpage>808</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXos1Srsrw%3D</pub-id><pub-id pub-id-type="doi">10.1038/nm.2399</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houlden</surname><given-names>A.</given-names></name><name><surname>Goldrick</surname><given-names>M.</given-names></name><name><surname>Brough</surname><given-names>D.</given-names></name><name><surname>Vizi</surname><given-names>E.S.</given-names></name><name><surname>Lénárt</surname><given-names>N.</given-names></name><name><surname>Martinecz</surname><given-names>B.</given-names></name><name><surname>Roberts</surname><given-names>I.S.</given-names></name><name><surname>Denes</surname><given-names>A.</given-names></name></person-group><article-title xml:lang="en">Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production</article-title><source>Brain, Behavior, and Immunity</source><year>2016</year><volume>57</volume><fpage>10</fpage><lpage>20</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XmtFClsb4%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.bbi.2016.04.003</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>Shu Wen</given-names></name><name><surname>Wong</surname><given-names>Connie H. Y.</given-names></name></person-group><article-title xml:lang="en">An unexplored brain-gut microbiota axis in stroke</article-title><source>Gut Microbes</source><year>2017</year><volume>8</volume><issue>6</issue><fpage>601</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1080/19490976.2017.1344809</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Stanley D, Moore RJ, Wong CHY. An insight into intestinal mucosal microbiota disruption after stroke. Sci Rep. 2018;8(1):568.</mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benakis</surname><given-names>Corinne</given-names></name><name><surname>Brea</surname><given-names>David</given-names></name><name><surname>Caballero</surname><given-names>Silvia</given-names></name><name><surname>Faraco</surname><given-names>Giuseppe</given-names></name><name><surname>Moore</surname><given-names>Jamie</given-names></name><name><surname>Murphy</surname><given-names>Michelle</given-names></name><name><surname>Sita</surname><given-names>Giulia</given-names></name><name><surname>Racchumi</surname><given-names>Gianfranco</given-names></name><name><surname>Ling</surname><given-names>Lilan</given-names></name><name><surname>Pamer</surname><given-names>Eric G</given-names></name><name><surname>Iadecola</surname><given-names>Costantino</given-names></name><name><surname>Anrather</surname><given-names>Josef</given-names></name></person-group><article-title xml:lang="en">Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells</article-title><source>Nature Medicine</source><year>2016</year><volume>22</volume><issue>5</issue><fpage>516</fpage><lpage>523</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XkvFShurk%3D</pub-id><pub-id pub-id-type="doi">10.1038/nm.4068</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherwin</surname><given-names>E</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group><article-title xml:lang="en">Recent developments in understanding the role of the gut microbiota in brain health and disease</article-title><source>Ann N Y Acad Sci</source><year>2018</year><volume>1420</volume><issue>1</issue><fpage>5</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1111/nyas.13416</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winek</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Depletion of cultivatable gut microbiota by broad-Spectrum antibiotic pretreatment worsens outcome after murine stroke</article-title><source>Stroke</source><year>2016</year><volume>47</volume><issue>5</issue><fpage>1354</fpage><lpage>1363</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XmvFSmt7Y%3D</pub-id><pub-id pub-id-type="doi">10.1161/STROKEAHA.115.011800</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashiro</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><issue>2</issue><fpage>e0171521</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0171521</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack</article-title><source>J Am Heart Assoc</source><year>2015</year><volume>4</volume><issue>11</issue><fpage>e002699</fpage><pub-id pub-id-type="doi">10.1161/JAHA.115.002699</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>W</given-names></name><etal/></person-group><article-title xml:lang="en">Analysis of intestinal microbial communities of cerebral infarction and ischemia patients based on high throughput sequencing technology and glucose and lipid metabolism</article-title><source>Mol Med Rep</source><year>2017</year><volume>16</volume><issue>4</issue><fpage>5413</fpage><lpage>5417</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXpsFSjsQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.3892/mmr.2017.7227</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vital</surname><given-names>M</given-names></name><name><surname>Howe</surname><given-names>AC</given-names></name><name><surname>Tiedje</surname><given-names>JM</given-names></name></person-group><article-title xml:lang="en">Revealing the bacterial butyrate synthesis pathways by analyzing (meta) genomic data</article-title><source>MBio</source><year>2014</year><volume>5</volume><issue>2</issue><pub-id pub-id-type="doi">10.1128/mBio.00889-14</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cani</surname><given-names>PD</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name></person-group><article-title xml:lang="en">Next-generation beneficial microbes: the case of Akkermansia muciniphila</article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><fpage>1765</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01765</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoetendal</surname><given-names>EG</given-names></name><etal/></person-group><article-title xml:lang="en">Victivallis vadensis gen. Nov., sp. nov., a sugar-fermenting anaerobe from human faeces</article-title><source>Int J Syst Evol Microbiol</source><year>2003</year><volume>53</volume><issue>Pt 1</issue><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1099/ijs.0.02362-0</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>JH</given-names></name><etal/></person-group><article-title xml:lang="en">Short chain fatty acids in human large intestine, portal, hepatic and venous blood</article-title><source>Gut</source><year>1987</year><volume>28</volume><issue>10</issue><fpage>1221</fpage><lpage>1227</lpage><pub-id pub-id-type="coi">1:STN:280:DyaL1c%2Fls1CrsA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1136/gut.28.10.1221</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">From dietary Fiber to host physiology: short-chain fatty acids as key bacterial metabolites</article-title><source>Cell</source><year>2016</year><volume>165</volume><issue>6</issue><fpage>1332</fpage><lpage>1345</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xpslaltro%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.041</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Zhai Q, et al. A next generation probiotic, Akkermansia muciniphila. Crit Rev Food Sci Nutr. 2018; <ext-link xlink:href="https://doi.org/10.1080/10408398.2018.1517725" ext-link-type="doi">https://doi.org/10.1080/10408398.2018.1517725</ext-link>. [Epub ahead of print].</mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>8770</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-09395-8</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of Claudin-2</article-title><source>J Immunol</source><year>2017</year><volume>199</volume><issue>8</issue><fpage>2976</fpage><lpage>2984</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhs1amtbbJ</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1700105</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Lukovac S, et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio. 2014;5(4).</mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanninen</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice</article-title><source>Gut</source><year>2018</year><volume>67</volume><issue>8</issue><fpage>1445</fpage><lpage>1453</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2017-314508</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Kamtchum-Tatuene J, Jickling GC. Blood biomarkers for stroke diagnosis and management. NeuroMolecular Med. 2019.</mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>QW</given-names></name><etal/></person-group><article-title xml:lang="en">Triglyceride to high-density lipoprotein cholesterol ratio predicts worse outcomes after acute ischaemic stroke</article-title><source>Eur J Neurol</source><year>2017</year><volume>24</volume><issue>2</issue><fpage>283</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1111/ene.13198</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dieplinger</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Prognostic value of inflammatory and cardiovascular biomarkers for prediction of 90-day all-cause mortality after acute ischemic stroke-results from the Linz stroke unit study</article-title><source>Clin Chem</source><year>2017</year><volume>63</volume><issue>6</issue><fpage>1101</fpage><lpage>1109</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXht1OgsL3M</pub-id><pub-id pub-id-type="doi">10.1373/clinchem.2016.269969</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>XL</given-names></name><etal/></person-group><article-title xml:lang="en">Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke</article-title><source>Acta Neurol Scand</source><year>2017</year><volume>136</volume><issue>2</issue><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhtVyqsr7E</pub-id><pub-id pub-id-type="doi">10.1111/ane.12688</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tall</surname><given-names>AR</given-names></name></person-group><article-title xml:lang="en">Plasma high density lipoproteins: therapeutic targeting and links to atherogenic inflammation</article-title><source>Atherosclerosis</source><year>2018</year><volume>276</volume><fpage>39</fpage><lpage>43</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhtlekt77P</pub-id><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2018.07.004</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prospective Studies</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths</article-title><source>Lancet</source><year>2007</year><volume>370</volume><issue>9602</issue><fpage>1829</fpage><lpage>1839</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(07)61778-4</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1"><sec id="Sec16"><title>Additional files</title><p id="Par38"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Additional files"><media xlink:href="MediaObjects/12866_2019_1552_MOESM1_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p><bold>Table S1.</bold> The serum index of CI patient and healthy control. (PDF 140 kb)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" xlink:title="Additional files"><media xlink:href="MediaObjects/12866_2019_1552_MOESM2_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p><bold>Table S2.</bold> The severity and outcome of CI patients. (PDF 107 kb)</p></caption></media></supplementary-material></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>CI</term><def><p id="Par5">Cerebral ischemic stroke</p></def></def-item><def-item><term>GLU</term><def><p id="Par6">Glucose of blood</p></def></def-item><def-item><term>HCY</term><def><p id="Par7">Homocysteine</p></def></def-item><def-item><term>HDL</term><def><p id="Par8">High-density lipoprotein</p></def></def-item><def-item><term>LDL</term><def><p id="Par9">Low-density lipoprotein</p></def></def-item><def-item><term>OTU</term><def><p id="Par10">Operational taxonomic unit</p></def></def-item><def-item><term>TG</term><def><p id="Par11">Triglycerides</p></def></def-item><def-item><term>UA</term><def><p id="Par12">Uric acid</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Biological Microscopy</facet-value><facet-value count="1">Life Sciences</facet-value><facet-value count="1">Life Sciences, general</facet-value><facet-value count="1">Microbiology</facet-value><facet-value count="1">Mycology</facet-value><facet-value count="1">Parasitology</facet-value><facet-value count="1">Virology</facet-value></facet><facet name="keyword"><facet-value count="1">Cerebral ischemic stroke</facet-value><facet-value count="1">Dysbiosis</facet-value><facet-value count="1">Microbiota</facet-value><facet-value count="1">Outcomes</facet-value></facet><facet name="pub"><facet-value count="1">BMC Microbiology</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">China</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
